The COVID-19 outbreak created a global disruption in clinical trials and companies looking worldwide for innovative approaches to ensure patient´s treatment and study continuity.
This ISPE online event will kick-off a series of Discussion Panels to share learnings about
How to adapt to direct-to-patient and virtual trials in a post-COVID world – The new normal
Listen to and discuss with top class speakers representing relevant perspectives of the clinical supply chain such as Clinical Trial Supply and Clinical Operations Representatives from EU and US Pharma companies. Gain insights into experiences of the key supplier network for e.g. IxRS snd distribution. Bring in your experience and benefit from knowledge sharing like remote monitoring, regulations and compliance, disruption of IMP / data oversight, etc.
This virtual discussion panel will be a crucial platform for professionals to learn about how to adapt to direct-to-patient and virtual trials in a COVID and post-COVID world.